137 related articles for article (PubMed ID: 12501117)
1. Recent developments in pharmacotherapy for the acutely psychotic patient.
Daniel DG
J Emerg Nurs; 2002 Dec; 28(6 Suppl):S12-20. PubMed ID: 12501117
[No Abstract] [Full Text] [Related]
2. Continuum of care: stabilizing the acutely agitated patient.
Bellnier TJ
Am J Health Syst Pharm; 2002 Sep; 59(17 Suppl 5):S12-8. PubMed ID: 12227082
[TBL] [Abstract][Full Text] [Related]
3. The utility of intramuscular ziprasidone in the management of acute psychotic agitation.
Mendelowitz AJ
Ann Clin Psychiatry; 2004; 16(3):145-54. PubMed ID: 15517847
[TBL] [Abstract][Full Text] [Related]
4. Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone.
Baldaçara L; Sanches M; Cordeiro DC; Jackoswski AP
Braz J Psychiatry; 2011 Mar; 33(1):30-9. PubMed ID: 21537720
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia.
Breier A; Meehan K; Birkett M; David S; Ferchland I; Sutton V; Taylor CC; Palmer R; Dossenbach M; Kiesler G; Brook S; Wright P
Arch Gen Psychiatry; 2002 May; 59(5):441-8. PubMed ID: 11982448
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia.
Wright P; Birkett M; David SR; Meehan K; Ferchland I; Alaka KJ; Saunders JC; Krueger J; Bradley P; San L; Bernardo M; Reinstein M; Breier A
Am J Psychiatry; 2001 Jul; 158(7):1149-51. PubMed ID: 11431240
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of a rapid-acting intramuscular formulation of olanzapine for positive symptoms.
Jones B; Taylor CC; Meehan K
J Clin Psychiatry; 2001; 62 Suppl 2():22-4. PubMed ID: 11232747
[TBL] [Abstract][Full Text] [Related]
8. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol.
Andrezina R; Josiassen RC; Marcus RN; Oren DA; Manos G; Stock E; Carson WH; Iwamoto T
Psychopharmacology (Berl); 2006 Oct; 188(3):281-92. PubMed ID: 16953381
[TBL] [Abstract][Full Text] [Related]
9. Calming versus sedative effects of intramuscular olanzapine in agitated patients.
Battaglia J; Lindborg SR; Alaka K; Meehan K; Wright P
Am J Emerg Med; 2003 May; 21(3):192-8. PubMed ID: 12811711
[TBL] [Abstract][Full Text] [Related]
10. Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial.
Huang CL; Hwang TJ; Chen YH; Huang GH; Hsieh MH; Chen HH; Hwu HG
J Formos Med Assoc; 2015 May; 114(5):438-45. PubMed ID: 25791540
[TBL] [Abstract][Full Text] [Related]
11. Injectable atypical antipsychotics for agitation in borderline personality disorder.
Pascual JC; Madre M; Soler J; Barrachina J; Campins MJ; Alvarez E; Pérez V
Pharmacopsychiatry; 2006 May; 39(3):117-8. PubMed ID: 16721704
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of antipsychotic drugs.
Meibach RC
Am J Psychiatry; 2003 Mar; 160(3):589-90; author reply 592-3. PubMed ID: 12611851
[No Abstract] [Full Text] [Related]
13. The efficacy of olanzapine, as needed, to treat acute agitation in juveniles.
Sheikh RM; Ahmed K
J Child Adolesc Psychopharmacol; 2002; 12(1):71-3. PubMed ID: 12014599
[No Abstract] [Full Text] [Related]
14. A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy.
Wright P; Meehan K; Birkett M; Lindborg SR; Taylor CC; Morris P; Breier A
Clin Ther; 2003 May; 25(5):1420-8. PubMed ID: 12867218
[TBL] [Abstract][Full Text] [Related]
15. Combination of olanzapine and divalproex for agitation in individuals with profound mental retardation.
Olson DA; Ingram W; Mann JR
J Clin Psychopharmacol; 2002 Oct; 22(5):529-30. PubMed ID: 12352281
[No Abstract] [Full Text] [Related]
16. [New formulations of olanzapine in the treatment of acute agitation].
Bartkó G
Neuropsychopharmacol Hung; 2006 Dec; 8(4):171-8. PubMed ID: 17211052
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania.
Meehan K; Zhang F; David S; Tohen M; Janicak P; Small J; Koch M; Rizk R; Walker D; Tran P; Breier A
J Clin Psychopharmacol; 2001 Aug; 21(4):389-97. PubMed ID: 11476123
[TBL] [Abstract][Full Text] [Related]
18. Intramuscular Midazolam, Olanzapine, Ziprasidone, or Haloperidol for Treating Acute Agitation in the Emergency Department.
Klein LR; Driver BE; Miner JR; Martel ML; Hessel M; Collins JD; Horton GB; Fagerstrom E; Satpathy R; Cole JB
Ann Emerg Med; 2018 Oct; 72(4):374-385. PubMed ID: 29885904
[TBL] [Abstract][Full Text] [Related]
19. A retrospective analysis of intramuscular haloperidol and intramuscular olanzapine in the treatment of agitation in drug- and alcohol-using patients.
MacDonald K; Wilson MP; Minassian A; Vilke GM; Perez R; Cobb P; Tallian K; Becker O; Feifel D
Gen Hosp Psychiatry; 2010; 32(4):443-5. PubMed ID: 20633750
[TBL] [Abstract][Full Text] [Related]
20. Rationale and guidelines for the inpatient treatment of acute psychosis.
Feifel D
J Clin Psychiatry; 2000; 61 Suppl 14():27-32. PubMed ID: 11154014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
